K Number
K210904
Device Name
Metapaste Plus
Date Cleared
2021-06-30

(96 days)

Product Code
Regulation Number
872.3820
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
Metapaste Plus is a biocompatible root canal filling used for the temporary filling of root canals after endodontic surgery. Metapaste Plus can be used on its own and for vital pulpotomy in deciduous teeth. Metapaste Plus is intended for use by qualified healthcare personnel trained in its use.
Device Description
Metapaste Plus is a water-based calcium hydroxide paste material for root canal temporary filling. It is pre-mixed in a syringe for convenient delivery in the root canal. When applied to root canal, it is alkaline by calcium hydroxide. The state of the treatment can be confirmed by the radiopacity of barium sulfate contained. Also, it is water-soluble and easy to remove.
More Information

Not Found

No
The summary describes a calcium hydroxide paste for root canal filling and does not mention any AI or ML components or functionalities.

Yes
The device is described as a "root canal filling used for the temporary filling of root canals after endodontic surgery," which indicates a therapeutic purpose.

No

Metapaste Plus is a temporary filling material used after endodontic surgery and for vital pulpotomy. Its function is to fill root canals and its "state of the treatment can be confirmed by the radiopacity of barium sulfate contained," which implies monitoring the treatment's progression rather than diagnosing a condition. It treats a condition, it does not diagnose one.

No

The device description clearly states it is a "water-based calcium hydroxide paste material" and is "pre-mixed in a syringe," indicating it is a physical substance and delivery mechanism, not software.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is for "temporary filling of root canals after endodontic surgery" and "vital pulpotomy in deciduous teeth." This is a direct therapeutic application within the body, not a diagnostic test performed on samples taken from the body.
  • Device Description: The description details a material applied directly to the root canal, not a reagent or instrument used to analyze biological samples.
  • Lack of Diagnostic Purpose: There is no mention of the device being used to diagnose a condition, measure a substance in a sample, or provide information for diagnostic purposes.

IVD devices are used to examine specimens derived from the human body (like blood, urine, tissue) to provide information for diagnostic, monitoring, or compatibility purposes. Metapaste Plus is a material used in the body for a therapeutic purpose.

N/A

Intended Use / Indications for Use

Metapaste Plus is a biocompatible root canal filling used for the temporary filling of root canals after endodontic surgery. Metapaste Plus can be used on its own and for vital pulpotomy in deciduous teeth.

Metapaste Plus is intended for use by qualified healthcare personnel trained in its use.

Product codes (comma separated list FDA assigned to the subject device)

KIF

Device Description

Metapaste Plus is a water-based calcium hydroxide paste material for root canal temporary filling. It is pre-mixed in a syringe for convenient delivery in the root canal. When applied to root canal, it is alkaline by calcium hydroxide. The state of the treatment can be confirmed by the radiopacity of barium sulfate contained. Also, it is water-soluble and easy to remove.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Root canals (dental)

Indicated Patient Age Range

Not Found

Intended User / Care Setting

qualified healthcare personnel trained in its use

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Non-clinical Testing:

  • Performance testing of Appearance, Weight, Packaging according to Manufacturer standard.
  • Performance testing of Flowability and Radio-opacity according to ISO 6876:2012.
  • Biocompatibility Tests according to EN ISO 10993-1:2009, EN ISO 10993-3:2014, EN ISO 10993-5:2009, EN ISO 10993-6:2009, EN ISO 10993-10:2013, EN ISO 10993-11:2017.
  • Shelf Life test: Manufacturer standard tests (Appearance, Packaging), ISO 6876:2012 tests (Flowability, Radio-opacity)

Key Results:

  • Flowability: 21mm (meets ISO 6876 requirement > 17mm)
  • Radio-opacity: 3.1mm (meets ISO 6876 requirement of not less than 3 mm of aluminium)
  • Biocompatibility: Yes (proved by performing tests in accordance with ISO 10993-1)
  • Shelf Life: 2 years

Conclusion: Based on documentation supplied with this submissions drawn from the testing results demonstrate that the subject device is substantially equivalent to our legally marketed predicate device.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K032605, Metapaste by Meta Biomed Co., Ltd.

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 872.3820 Root canal filling resin.

(a)
Identification. A root canal filling resin is a device composed of material, such as methylmethacrylate, intended for use during endodontic therapy to fill the root canal of a tooth.(b)
Classification. (1) Class II if chloroform is not used as an ingredient in the device.(2) Class III if chloroform is used as an ingredient in the device.
(c)
Date PMA or notice of completion of a PDP is required. A PMA or a notice of completion of a PDP is required to be filed with the Food and Drug Administration on or before December 26, 1996 for any root canal filling resin described in paragraph (b)(2) of this section that was in commercial distribution before May 28, 1976, or that has, on or before December 26, 1996 been found to be substantially equivalent to a root canal filling resin described in paragraph (b)(2) of this section that was in commercial distribution before May 28, 1976. Any other root canal filling resin shall have an approved PMA or a declared completed PDP in effect before being placed in commercial distribution.

0

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which consists of the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG" in blue, with the word "ADMINISTRATION" underneath in a smaller font.

June 30, 2021

Meta Biomed Co., Ltd. April Lee Consultant Withus Group Inc 106 Superior Irvine, California 92620

Re: K210904

Trade/Device Name: Metapaste Plus Regulation Number: 21 CFR 872.3820 Regulation Name: Root Canal Filling Resin Regulatory Class: Class II Product Code: KIF Dated: March 15, 2021 Received: March 26, 2021

Dear April Lee:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's

1

requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Michael E. Adjodha, M.ChE. Assistant Director DHT1B: Division of Dental and ENT Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

2

Indications for Use

510(k) Number (if known)

K210904

Device Name Metapaste Plus

Indications for Use (Describe)

Metapaste Plus is a biocompatible root canal filling used for the temporary filling of root canals after endodontic surgery. Metapaste Plus can be used on its own and for vital pulpotomy in deciduous teeth.

Metapaste Plus is intended for use by qualified healthcare personnel trained in its use.

Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 201 Subpart D)
Over-The-Counter Use (21 CFR 201 Subpart C)

Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

Image /page/3/Picture/0 description: The image shows the logo for Meta Biomed. The logo consists of a stylized tooth shape on the left, with the top half in dark blue and the bottom half in teal. To the right of the tooth shape is the text "META" in dark blue, with a registered trademark symbol above and to the right of the "A". Below "META" is the text "BIOMED" in teal.

Address
270, Osongsaengmyeong 1-ro,
Osong-eup, Heungdeok-gu,
Cheongju-si, Chungcheongbuk-do,
Korea

Tel
+82-43-216-0433

Fax
+82-43-217-1988

METABIOMED CO.LTD.
E-mail
info@meta-biomed.com
http://www.meta-biomed.com

510(k) Summary K210904

Submitter

META BIOMED CO., LTD. Suk Song Oh 270, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, South Korea 28161 Email: ef1459@meta-biomed.com Phone: +82-43-230-8841 Fax: +82-43-217-1983

Official Correspondent

Withus Group Inc April Lee 106 Superior, Irvine, CA 92620 USA Email: withus6664@gmail.com Phone: 1-909-274-9971 Fax: 1-909-460-8122

Device Information

  • Trade Name: Metapaste Plus
  • Classification Name: Resin, Root Canal Filling .
  • Product Code: KIF
  • Panel: Dental
  • Regulation Number: 21 CFR 872.3820
  • Device Class: Class II
  • Date prepared: 03/15/2021

Predicate Devices:

Primary Predicate

  • . K032605, Metapaste by Meta Biomed Co., Ltd.

Device Description

Metapaste Plus is a water-based calcium hydroxide paste material for root canal temporary filling. It is pre-mixed in a syringe for convenient delivery in the root canal. When applied to root canal, it is alkaline by calcium hydroxide. The state of the treatment can be confirmed by the radiopacity of barium sulfate contained. Also, it is water-soluble and easy to remove.

Indication for Use

Metapaste Plus is a biocompatible root canal filling used for the temporary filling of root canals after endodontic surgery. Metapaste Plus can be used on its own and for vital pulpotomy in deciduous teeth. Metapaste Plus is intended for use by qualified healthcare personnel trained in its use.

4

Image /page/4/Picture/0 description: The image shows the logo for META BIOMED. The logo consists of a stylized tooth icon on the left, with the word "META" above the word "BIOMED" on the right. The tooth icon is divided horizontally, with the top half in dark blue and the bottom half in teal. The words "META" and "BIOMED" are also in dark blue and teal, respectively, with a registered trademark symbol next to the word "META".

Address 270, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, Korea

Tel +82-43-216-0433 Fax +82-43-217-1988

E-mail
info@meta-biomed.com http://www.meta-biomed.com

Summary of Technological Characteristics:

Subject DevicePredicate Device
ManufacturerMeta Biomed Co., Ltd.Meta Biomed Co., Ltd.
Device NameMetapaste PlusMetapaste
510(k) NumberNAK032605
Classification Nameresin, root canal fillingresin, root canal filling
Product CodeKIFKIF
Regulation Number21 CFR 872.382021 CFR 872.3820
Indications for useMetapaste Plus is a biocompatible root
canal filling used for the temporary filling
of root canals after endodontic surgery.
Metapaste Plus can be used on its own
and for vital pulpotomy in deciduous
teeth.
Metapaste Plus is intended for use by
qualified healthcare personnel trained in
its use.Metapaste is a biocompatible root canal
sealer used for the temporary filling of
root canals after endodontic surgery.
Metapaste can be used on its own and
for vital pulpectomies in deciduous
teeth.
Metapaste is intended for use by
qualified healthcare personnel trained in
its use.
Raw MaterialCalcium hydroxide
Barium sulfate
Aluminum oxide
Titanium oxide
Polyethylene glycol
Dihydrogen oxideCalcium hydroxide
Barium sulfate
Polypropylene glycol
Principle of OperationMetapaste Plus is a biocompatible root
canal sealer used for the temporary filling
of root canals after endodontic surgery.Metapaste is a biocompatible root canal
sealer used for the temporary filling of
root canals after endodontic surgery.
Performance Standard
ConformanceConformed to ISO 6876Conformed to ISO 6876
Flowability21mm12mm
Radio-opacity3.1mm3.4mm
BiocompatibilityYesYes
SterilityNon-sterileNon-sterile
Shelf Life2 years2 years

5

Image /page/5/Picture/0 description: The image shows the logo for Meta Biomed. The logo consists of a stylized tooth shape on the left, with the top half in dark blue and the bottom half in teal. To the right of the tooth shape is the text "META" in dark blue, with a registered trademark symbol next to it. Below "META" is the text "BIOMED" in teal. The logo is simple and modern, and the colors are clean and professional.

Address
270, Osongsaengmyeong 1-ro,
Osong-eup, Heungdeok-gu,
Cheongju-si, Chungcheongbuk-do,
Korea

tel
82-43-216-0433

fax
82-43-217-1988

METABIOMED CO.LTD.

E-mail
info@meta-biomed.com

http://www.meta-biomed.com

The subject device and the primary predicate have the similar indications, principle of operation, technological characteristics and materials. They encompass the same range of physical and chemical properties. The subject device and predicate devices are packaged in similar material and use similar methods of application.

Compared to the primary predicate, Indications for Use, flowability, Radio-opacity and material of the subject device are different.

1) Indications for Use
Metapaste PlusMetapaste (K032605)Discussion
Metapaste Plus is a
biocompatible root canal
filling used for the
temporary filling of root
canals after endodontic
surgery. Metapaste Plus
can be used on its own and
for vital pulpotomy in
deciduous teeth.
Metapaste Plus is intended
for use by qualified
healthcare personnel
trained in its useMetapaste is a biocompatible root
canal sealer used for the
temporary filling of root canals
after endodontic surgery.
Metapaste can be used on its own
and for vital pulpectomies in
deciduous teeth.
Metapaste is intended for use by
qualified healthcare personnel
trained in its usesubject device (Metapaste plus) and predicate
device (Metapaste) are temporary root canal
filling materials. The Indication for Use of subject
device (Metapaste Plus) and predicate device
(Metapaste) has same contents. In the Metapaste
Plus Indication for Use, there is content of
pulpotomy that is not found in Indication of use of
Metapaste.
It is a technique commonly used of temporary root
canal fillings and as such does not affect the
equivalence of Indication of subject and predicate
devices.
    1. The flowability between the subject and primary predicate is different; however, the flow of dental root canal filling material shall be more than 17mm in accordance with ISO 6876: 2012 test method, which is the subject device's flowability value meet the ISO 6876 requirements. Therefore, this difference doesn't impact the clinical performance of the product and substantial equivalence.
    1. The Radio-opacity between the subject and primary predicate is different; however, the Radioopacity of dental root canal filling material shall have a radio opacity equivalent to not less than 3 mm of aluminium in accordance with ISO 6876: 2012 test method, which is the subject device's Radio-opacity value meet the ISO 6876 requirements. Therefore, this difference doesn't impact the clinical performance of the product and substantial equivalence.
    1. The raw materials of subject device and the predicate device have a little difference in specific components and their composition. However, both products belong to calcium hydroxide paste. demonstrating their clinical safety and the biocompatibility of subject device has been proved by performing tests required for evaluating its biocompatibility in accordance with ISO10993-1. For this reason, although there is difference of raw materials between subject device and predicate device, it does not affect the clinical safety of subject device.

6

Image /page/6/Picture/0 description: The image contains a logo for Meta Biomed. The logo consists of a stylized tooth icon on the left, with the word "META" above the word "BIOMED" on the right. The tooth icon is split into two colors, with the top half being a dark blue and the bottom half being a teal color. The words "META" and "BIOMED" are also in teal, and there is a registered trademark symbol next to the word "META".

Address
270, Osongsaengmyeong 1-ro,
Osong-eup, Heungdeok-gu,
Cheongju-si, Chungcheongbuk-do,
Korea

+82-43-216-0433 +82-43-217-1988

Tol

Non-clinical Testing

The following testing was conducted on our subject device:

  • Performance testing of Appearance, Weight, Packaging according to Manufacturer standard. o
  • Performance testing of Flowability and Radio-opacity according to ISO 6876:2012.
  • . Biocompatibility Tests according to EN ISO 10993-1:2009, EN ISO 10993-3:2014, EN ISO 10993-5:2009, EN ISO 10993-6:2009, EN ISO 10993-10:2013, EN ISO 10993-11:2017.
  • Shelf Life test: Manufacturer standard tests (Appearance, Packaging), ISO 6876:2012 tests ● (Flowability, Radio-opacity)

Conclusion:

Based on documentation supplied with this submissions drawn from the testing results demonstrate that the subject device is substantially equivalent to our legally marketed predicate device.